Amount Raised
$42 Million
Round Type
Series D
Salt Lake CityBiotechnologyTherapeuticsPharmaceuticalBiopharmaDescription
Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on the development of first-in-class nanocatalysts for the treatment of bioenergetic failure associated with neurodegenerative diseases, today announced the $42.5 million oversubscribed closing of its Series D equity financing. Proceeds from the financing will be used to advance Clene’s clinical pipeline—particularly the lead nanocatalyst, CNM-Au8—an orally administered therapeutic under investigation for the neurorepair of various neurodegenerative diseases including multiple sclerosis, Parkinson’s disease, and ALS, with one Phase 3 trial and four Phase 2 studies ongoing.
Quick answer
Clene Nanomedicine raised $42 Million in a Series D round, dated August 27, 2020. Clene Nanomedicine is based in Salt Lake City, Utah, United States.
- How much did Clene Nanomedicine raise?
- Clene Nanomedicine raised $42 Million in a Series D round on August 27, 2020.
- What does Clene Nanomedicine do?
- Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and..
- Where is Clene Nanomedicine based and how big is it?
- Clene Nanomedicine is based in Salt Lake City, Utah, United States. Fundz records about 78 employees.
- Who are the decision-makers at Clene Nanomedicine?
- Fundz holds 1 contact at Clene Nanomedicine, including the Vice President, Translational Medicine. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Clene Nanomedicine that raised within 45 days of this round, from Fundz verified event records.
- OnKure Therapeutics raised $1.5M (Seed) on September 30, 2020.
- Oragenics raised an undisclosed amount (Funding Round) on September 28, 2020.
- LAVA Therapeutics raised $83M (Series C) on September 17, 2020.
- Entero Therapeutics raised $22M on July 31, 2020.
- MBX Biosciences, Inc. raised $26M on July 27, 2020.
- MBX Biosciences, Inc. raised $34M (Series A) on July 27, 2020.
Who to call at Clene Nanomedicine, and when
A new round usually means Clene Nanomedicine is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Clene Nanomedicine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Clene Nanomedicine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Clene Nanomedicine. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Clene Nanomedicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Clene Nanomedicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.